<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">Cerebral vasospasm</z:e> is a well-known cause of mortality and morbidity following aneurysmal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="1" pm="."><plain>Prevention of symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> is the basic management after SAH </plain></SENT>
<SENT sid="2" pm="."><plain>Numerous pharmaceutical therapies and endovascular treatments are available against <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, but none of them have so far proven to improve the outcome </plain></SENT>
<SENT sid="3" pm="."><plain>We have focused on maintaining the circulation volume in order to prevent <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>But to maintain the central venous pressure, huge infusion volume was required, and <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> was frequently observed due to <z:mp ids='MP_0006316'>natriuresis</z:mp> and osmotic <z:mp ids='MP_0001762'>diuresis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Excessive <z:mp ids='MP_0006316'>natriuresis</z:mp> and <z:mp ids='MP_0001762'>diuresis</z:mp> cannot be managed through <z:chebi fb="199" ids="26708">sodium</z:chebi> and water replacement, since <z:chebi fb="199" ids="26708">sodium</z:chebi> replacement induces further <z:mp ids='MP_0006316'>natriuresis</z:mp> and <z:mp ids='MP_0001762'>diuresis</z:mp> (desalination), and water replacement induces <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>We therefore administered <z:chebi fb="0" ids="50885">fludrocortisone</z:chebi> and <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi> to inhibit excessive <z:mp ids='MP_0006316'>natriuresis</z:mp> and <z:mp ids='MP_0001762'>diuresis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>The efficacy of <z:chebi fb="199" ids="26708">sodium</z:chebi> reabsorption therapy is extremely high to maintain the circulation volume that might have a therapeutic effect to prevent <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In this article, we review our institution's experience regarding the management of patients with aneurysmal SAH and also discuss the importance of water and <z:chebi fb="199" ids="26708">sodium</z:chebi> balance when managing such patients </plain></SENT>
</text></document>